Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000555603 | SCV000654846 | benign | Arrhythmogenic right ventricular dysplasia 13 | 2025-01-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001727760 | SCV002008362 | likely benign | not provided | 2021-05-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001701084 | SCV002726661 | likely benign | not specified | 2022-02-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001727760 | SCV004125490 | likely benign | not provided | 2023-01-01 | criteria provided, single submitter | clinical testing | CTNNA3: BP4, BP7 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001701084 | SCV004241124 | benign | not specified | 2023-12-03 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001727760 | SCV005228078 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics, |
RCV001701084 | SCV001920898 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001727760 | SCV001970990 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004754470 | SCV005351493 | benign | CTNNA3-related disorder | 2024-04-25 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |